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1. Introduction 
Long-run economic growth and welfare resides on the production of new knowledge and its 
implementation into new or improved products or processes. For this reason, identification, 
evaluation and correction of the detrimental effects of potential under-investment in R&D activities 
have a prominent place in the policy agendas of all industrialized countries. This is particularly the 
case in Europe where, since the start of the recent economic crisis, the policy debate has been 
focussed on the role of capital market imperfections, as they increase the cost of R&D when firms do 
not have sufficient internal funds to finance it. The credit crunch, i.e. the lack of availability (or 
reduction in supply) of credit to businesses from traditional financial institutions, is said to reduce 
firms’ investment in innovative activities and growth prospects. However, despite its theoretical 
appeal and in contrast with the proven sensitivity of fixed capital investment to financing 
constraints, evidence on the susceptibility of R&D investment to financial frictions and, in particular, 
to credit rationing is still mixed and inconclusive.  
Three explanations have been put forward for the lack of robust evidence. First, it is claimed that the 
variety in the results reflects the contrast between theoretical explanations based on asymmetric 
information arguments (suggesting a sensitivity of R&D to financing constraints potentially higher 
than that of ordinary investment) and the characteristics of R&D as a long term investment with 
high adjustment costs (suggesting rather the opposite1). Second, existing evidence is based almost 
exclusively on the sensitivity of firm-level R&D spending to the availability of internal finance 
(typically measured through cash flow), which is however known to be problematic in its ability to 
proxy for financing constraints (Kaplan and Zingales, 1997 and 2000). Third, recent contributions 
have stressed the difficulty in identifying the role financing constraint using standard investment 
models when firms have access to multiple channels for raising external financial resources and 
managing buffer stocks of liquidity (Brown et al., 2011). 
In this study, we use firm-level data on R&D investment and credit constraints to measure the 
                                                 
1 See, for instance, Hall and Lerner (2010). 
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detrimental effect of credit rationing on R&D investment dealing with all the above specified issues . 
First, we claim that the ambiguity originated by information problems vs. the nature of R&D as a 
long term investment might be resolved if we distinguish between the probability of R&D 
investment (the R&D participation decision) and the size of R&D investment, once the decision to 
invest has been taken (the amount of R&D spending decision). We therefore study the effect of credit 
rationing on the decision to do R&D and on the amount of R&D investment: our hypothesis is that 
credit rationing displays a stronger effect on the first decision compared to the latter. While this 
expectation might seem obvious, to our knowledge econometric analyses on the topic have not yet 
addressed or proven the differential impact of credit rationing on the participation and amount 
decisions, respectively.  
Second, we avoid indirect identification of credit rationing through internal liquidity and exploit 
direct qualitative information on limits to credit availability to obtain an indicator of credit rationing 
and allow it to be endogenously determined. Our identification strategy is grounded in the 
theoretical models by Stiglitz and Weiss (1981) and Bester (1985). We innovatively employ the 
Whited and Wu (2006) index (WW) – a recently established indicator of need of external finance –
amongst the set of instruments for our direct indicator of credit rationing, along with collateral and a 
proxy for local banking development. We then use recent econometric methods developed by Conley 
et al (2011) to deal with concerns on the instruments’ exogeneity.  
Third, our sample of Italian SMEs provides an ideal testing ground for studying the relationship 
between credit rationing and R&D investment since it significantly reduces the effects of 
confounding factors, primarily the availability of alternative sources of external finance. Pecking 
order theory (Myers and Majluf, 1984) predicts that firms would first prefer debt finance such as 
bank loans to equity financing when internal financial resources appear to be insufficient. However, 
the alternative approach emphasizing control rights (Aghion and Bolton, 1992) suggests rather the 
opposite. Identifying the effect of credit restrictions on R&D investment would thus require 
controlling for firm’s equity financing availability and preferences over alternative sources of 
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external finance. SMEs in Italy represent a good setting for our study since equity issues are rare 
events for such firms (which are mostly unlisted and often family led firms). Also, they traditionally 
and heavily rely on bank financing as stock markets and venture capital are significantly less 
developed in Italy compared to the United States.2 
Finally, it should be emphasized that focussing on SMEs is worth doing for further reasons. First, 
SMEs account for a large share of enterprises in most countries, constituting, on average, over 60% 
of total employment in manufacturing and even more so in countries like Italy, where their share of 
total employment is 80% (Ayyagari et al, 2007). Second, theoretical reasoning suggests that young 
SMEs are likely to face higher costs of external finance and to be more constrained in their R&D 
investment decisions than large established firms. However, such firms may also have a pivotal role 
in bringing radically new innovations to the market and in promoting growth.  
Our analysis leads to three main results. First, we find that credit rationing significantly reduces 
both the likelihood to invest in R&D and the amount of resources invested in R&D. Second, the 
percentage reduction in R&D investment as a consequence of a firm being credit rationed is largely 
associated with the reduction in the likelihood to do R&D, rather than with a reduced amount of 
investment, conditioned on the investment decision. Finally, but importantly, we find that firms that 
are both young and small face additional difficulties in obtaining bank financing – even after 
controlling for both size and age – and display a higher probability of being credit rationed, ceteris 
paribus. This fully explains their reduced propensity and intensity of R&D investment, as we find no 
other direct effect associated with their young-small status. Our results thus confirm that that the 
emphasis attributed by European policy makers to the role of these companies in meeting the 
                                                 
2 In 1999, for example, the stock market had a capitalization of 66.1% relative to GDP, compared with 180.8% 
in the United States (Herrera and Minetti, 2007). The capitalization of the stock exchange Nuovo Mercato for 
high-growth firms relative to the GDP was 0.64% in June 2002, versus 20.54% of Nasdaq (Federation of 
European Stock Exchanges Statistics Database, 2002). In 2000, the ratio of venture capital investment to GDP 
was 0.26% compared with 1.24% in the United States (European Venture Capital Association, 2002 Yearbook) 
and there were only 18 business angels and incubators, compared to more than 800 in the United States (see 
also Herrera and Minetti, 2007). 
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Barcelona target3 is not ill posed and that appropriate policy measures should be directed towards 
alleviating their credit constraints in order to increase their R&D investment.  
The paper is organized as follows. Section 2 reviews the main economic issues and empirical 
contributions on financing constraints and R&D investment. Section 3 describes the data and survey 
information used in the empirical analysis. Section 4 presents our theoretical and econometric model 
and discusses our instrumental variable strategy. Section 5 reports and comments the estimation 
results. Section 6 concludes. 
 
2. Related literature 
Over the past decades, a number of studies have extended conventional models of business fixed 
investment to explicitly incorporate and account for the influence of financing constraints, once 
neglected in the neoclassical theory of investment. Theoretical models, departing from the 
conventional neoclassical assumptions, have provided foundations for the imperfect substitutability 
between external and internal funds and have thus justified the influence of financial factors on firm’s 
investment decisions. These models have illustrated the effects of informational asymmetries on 
investment in a moral hazard or adverse selection setting, where private information on project risk 
or quality induce a substantial difference between the cost of new debt and equity and the 
opportunity cost of using internal finance generated through cash flow and retained earnings (e.g. 
Stiglitz and Weiss, 1981; Myers and Majluf, 1984). Hence information costs and the availability of 
internal resources influence the firm’s shadow cost of external funds for fixed investment, holding 
underlying investment opportunities constant.  
Recent studies have argued that R&D investment might be even more sensitive to financial factors 
                                                 
3 The Barcelona European Council of 15-16 March 2002 announced targets for rising R&D investment from 
1.9% at that time, to close to 3% of GDP by 2010. The Council also stipulated that the private sector should 
provide two-thirds of the additional R&D investment. The 3% target was not met by 2010 in spite of a 
substantial increase of the overall EU R&D expenditure (+25% in real terms from 2000 to 2008) and progress 
achieved in a majority of Member States. Recognizing that Europe's future growth relies to a large extent on 
research and innovation, the European Council reaffirmed in March 2010 that the overall R&D investment 
level should be increased to 3% of EU GDP as part of improving the conditions for research and development. 
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than other types of investment.4 This is because outsiders may find it more difficult to make accurate 
appraisals of the value and risk of investment in intangible assets and in innovation-based physical 
investment. In addition, even if firms could costlessly transmit information to outsiders, strategic 
considerations may induce them to actively maintain information asymmetries, so to avoid the 
leaking of information to rivals, which would reduce the prospective value of innovation. Finally, it 
has also been noted that moral hazard and adverse selection problems add up to the absence of 
collateral value for investments in intangibles like R&D (Himmelberg and Petersen, 1994).  
Although plausible, a high sensitivity of R&D investment to credit rationing and, more generally, 
financing constraints might not be observed. This might be the consequence of two key features of 
R&D investment: (i) establishing an R&D program involves significant sunk costs and (ii) large 
fluctuations in the level of spending in existing research programs are very costly, as a consequence 
of the expenditures in R&D being predominantly payments to highly trained scientists, engineers 
and other specialists. These workers are not perfectly elastic in supply: firing and hiring them in 
accordance with temporary changes in business conditions would be extremely costly because they 
require firm-specific knowledge, because training new workers is expensive, and because fired 
specialists are able to transmit valuable knowledge to competitors (Hall, 1992).  
The existence of high adjustment costs for R&D might then imply that firms set the level of R&D 
investment in accordance with the permanent level of internal finance, so to minimize both current 
and future adjustment costs. Thus R&D should be relatively unresponsive to transitory movements 
in internal funds and credit rationing should then mostly affect the decision to set up R&D facilities 
(the R&D participation decision), rather than the decision about yearly level of spending in existing 
research programs (the amount of R&D spending decision).5  
All the considerations presented above might prove to be particularly relevant for SMEs. These 
firms are indeed less transparent, have higher relative transaction costs and fewer assets that can be 
used as collateral. This should be even more the case for firms that are small and young, as they add 
                                                 
4 See Hall (2002) and Hall and Lerner (2010) for extended reviews. 
5 See Bond et al (2003). 
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to the above mentioned difficulties further ones as low cumulated past profits, no long-term 
established relationships with local banks and high default risk. As a consequence, small and young 
firms are more likely to be credit rationed, ceteris paribus.  
Theoretical predictions on the role of size on financing constraints and investment have been 
confirmed by recent empirical evidence, suggesting that financing constraints in general are more 
severe for small-sized firms (Harhoff and Körting, 1998; Beck and Demirguc-Kunt, 2006; Benfratello 
et al., 2008; Czarnitzki, 2006; Czarnitzki and Hottenrott, 2011) and that smaller firms are more likely 
to face difficulties in conducting R&D and innovations projects because of lack of funding (see, for 
example, Himmelberg and Petersen, 1994; Hyytinen and Toivanen, 2005). Little evidence is instead 
available for young firms (Cincera, 2002; Savignac, 2008; Schneider and Veugelers, 2010).  
The use of indirect measures of financing constraints has represented the prevailing methodology in 
the empirical literature on financing constraints and investment. Most contributions have focussed 
on investment–cash flow sensitivity (Fazzari et al. 1988), others have used the well-known Kaplan 
and Zingales (KZ) index of constraints (Kaplan and Zingales, 1997), or the more recent Whited and 
Wu (WW) index of constraints (Whited and Wu, 2006), or a variety of different sorting criteria 
based on firm characteristics. The investment-cash flow sensitivity methodology relies on the 
estimation of a standard investment equation using either a neoclassical accelerator model or the 
Euler equation approach. A variable for the availability of internal finance is then added to the model 
(usually cash flow) and its significance (and correct sign) should signal the relevance of financing 
constraints in the firm's investment decisions.  
Econometric exercises have often relied on finding differential sensitivity to cash flow between sub-
samples of firms that are thought of being differentially affected by financing constraints a priori. 
This approach has three major drawbacks. First, the allocation of firms to “constrained” and 
“unconstrained” regimes is often based on outcomes which are at least partially chosen endogenously 
by firms (e.g. dividend payments, employment size, ...). Second, the results obtained within this line 
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of research have been quite inconclusive.6 Finally, and most importantly, a major problem exists with 
using cash flow as a proxy for financing constraints: the interpretation of cash flow is ambiguous 
because it contains information about expected future profitability, which may be relevant for 
investment decisions even with perfect capital markets. Hence, the sensitivity of investment to cash 
flow does not necessarily signal financing constraints7.  
Some recent contributions have exploited the availability of alternative direct indicators of financing 
constraints, which require appropriate treatment for their endogeneity (Aghion et al., 2010; 
Savignac, 2008; Hajivassiliou and Savignac, 2011; Tiwari et al., 2007). We follow this approach, but 
differently from these studies we focus on a direct indicator of credit rationing, rather than on a 
broader definition of financing constraints, and study its effects on R&D investment by separating its 
impact on the R&D participation decision and on the conditional R&D spending decision.  
 
3. Data 
Our data come from the Capitalia survey on Italian manufacturing firms undertaken in 2004 and 
covering the period 2001-2003. The sample of the survey is stratified according to industry, 
geographical location and size class for firms with 11 to 500 employees, while it includes all Italian 
firms with more than 500 employees. Here we will focus only on small and medium manufacturing 
enterprises, i.e. firms with less than 250 employees, which account for 90 percent of firms in the 
original sample, thus confirming their extremely relevant weight in Italy. 
The survey data is coupled with complete financial accounting data from AIDA8 for each fiscal year 
                                                 
6 Among the numerous studies, Himmelberg and Petersen (1994) find that internal finance is an important 
determinant of R&D expenditures. Harhoff (1998) finds strong or no the sensitivity of R&D to cash flow 
depending on the model specification adopted. Bond, Harhoff and Van Reenen (2003) show that financial 
constraints are significant in the UK economy while no effect is found for German firms, which can be 
explained by the institutional differences across the financial systems in the two countries. Cincera (2002) finds 
a positive impact of cash flow on the firms’ investment decisions, although these effects appear to play a 
considerably more important role for investment in physical capital than for R&D investment. Mulkay, Hall 
and Mairesse (2001) show that cash flow appears to be more important in the US than in France for any type of 
investment. 
7 See Kaplan and Zingales (1997, 2000) and, in a different setting, Clementi and Hopenhayn (2006). 
8 AIDA is the country based version of AMADEUS for Italy. Data comes from the specialized information 
provider Honyvem BilancItalia, which purchases and revises balance sheets from the Italian Chambers of 
Commerce. 
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from 2001 to 2003. Balance sheet data are not available for all the firms in the survey, hence our final 
sample of 2,144 SMEs9 is smaller than the manufacturing sample of  2,991 SMEs firms included in 
the original Capitalia survey, but this does not significantly alter the firms’ distribution by size 
classes, industry and geographical location (Table 1).  
 
Table 1 – Firms’ distribution by stratification variables 
 
Survey manufacturing 
sample Final sample 
Frequency Percentage Frequency Percentage 
Size class      
11-20 816 27.28 569 26.54 
21-50 1,057 35.34 775 36.15 
51-250 1,118 37.38 800 37.31 
Industry     
Food/Tobacco 334 11.17 246 11.47 
Textiles 462 15.45 359 16.74  
Wood/Paper/Print 259 8.66 188 8.77  
Chemicals/Coke 156 5.22 113 5.27 
Plastic/Rubber 160 5.35 97 4.52 
Glass/Ceramics 181 6.05 138 6.44 
Metals 565 18.89 381 17.77 
Machinery 392 13.11 276 12.87 
Electrical/Medicals 214 7.15 140 6.53 
Veichles 59 1.97 42 1.96 
Furnitures 209 6.99 164 7.65 
Geographical area     
North-West 1,072 35.84 728 33.96 
North-East 930 31.09 690 32.18 
Centre 547 18.29 408 19.03 
South 440 14.71 318 14.83 
No response 2 0.07 - - 
Total 2,991 100.00 2,144 100.00 
 
The survey includes a question asking the respondent to indicate whether the firm desired additional 
bank financing at the interest rate agreed with the main partner bank in 2003 (i.e. the last year 
covered by the survey). We classify the firm as being subject to credit rationing if the answer to the 
above question is positive and define our credit rationing indicator accordingly (rationed = 1). This 
                                                 
9 These also exclude a few firms with unreliable balance sheet information, a few outliers and firms with 
missing values for the relevant variables of interest. 
 9
indicator has been recently used by Angelini and Generale (2008) to study the effect of financing 
constraints on firm’s growth and provides a direct measure of credit rationing given by the firms 
themselves.10  
The financial system in Italy is strongly bank-based, with other sources of firm financing being much 
less developed.11 Using survey data from 48 countries and comparing financing patterns across them, 
Beck et al. (2008) find that Italy is the country with the highest proportion of investment financed by 
banks, with a share equal to 49.67, which accounts for 64% of external finance.12 The limited 
availability and use of alternative sources of external finance (other than bank loans) is helpful for the 
purpose of our study, since it reduces the effect of potential confounding factors caused by the firm’s 
unobserved preferences when choosing its optimal external financial channel (debt, equity, venture 
capital, etc.). 
 
Table 2 - Firms’ distribution by credit rationing and innovative status  (row percentage in parenthesis) 




rationed=No 1,537 (65.21) 820 (34.79) 2,357 (100) 
rationed=Yes 267 (64.49) 147 (35.51) 414 (100) 
Total 1,804 (65.10) 967 (34.90) 2,771 (100) 
Final 
Sample 
rationed=No 1,212 (65.94) 626 (34.06) 1,838(100) 
rationed=Yes 197 (64.38) 109 (35.62) 306 (100) 
Total 1,409 (65.72) 735 (34.28) 2,144 (100) 
 
Each firm participating to the survey is asked whether it has pursued any in-house R&D investment 
and, if so, to report the amount of money spent on such investment.13 Table 2 reports frequencies of 
firms with R&D investment in 2003 for both the rationed and not rationed groups and interestingly 
                                                 
10 Other recent related contributions using the same data and indicator are Piga and Atzeni (2007), Herrera 
and Minetti (2007), Benfratello et al (2008) and Becchetti et al. (2009). 
11 In Italy, bank debts account for about 75% of financial debts and while differences in the financial structures 
of firms located in other EU countries are not significant, those with the US are still large, especially for what 
concerns the bond market. Furthermore, the share of venture capital investment over GDP in Italy is 
extremely low, even compared to the European average (see Hall and Lerner, 2010). 
12 The corresponding figure for the US is 21.47 and accounts for about 45% of external financing. 
13 In order to check for consistency and to fill some missing values of the R&D expenditures figures in the 
Capitalia Survey we used additional information from another survey released yearly by the Italian Institute of 
Statistics (ISTAT) called “Ricerca e Sviluppo intra-muros (R&S) in Italia”. This allowed us to replace 130 
missing values in the original Capitalia R&D data. 
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shows that the relative share of R&D active firms is not significantly different in the two groups. If 
anything, the probability of doing R&D appears slightly higher in the group of firms subject to credit 
rationing. As we shall discuss  in the next sections, this is suggestive of a key source of endogeneity 
originating from firms’ self selection. Finally, Table 2 once again shows that the reduction in the 
sample due to balance sheet data availability does not induce any lack of representativeness. 
 
4. Estimation strategy 
Our self reported indicator of credit rationing is based on the firm’s perceived shortage of bank debt 
financing with respect to its desired level at the agreed interest rate. As we discuss in Section 5, the 
main source of endogeneity for this indicator is self-selection driven by unobserved heterogeneity 
(Imbens and Angrist, 1994; Heckman et al., 2006) which may result in spurious positive correlation 
with R&D investment. This is mostly due to the presence of a large group of firms with little or no 
attitute towards innovation, which are consequently unlikely to perceive themselves as rationed.14 
Therefore, in this section we describe our estimation strategy, which is designed to account for the 
endogeneity of the credit rationing indicator and aimed at identifying its effect on R&D investment. 
We first present the theoretical framework and then describe the econometric model and the 
identification strategy. Finally, we discuss our instruments in the last subsection. 
 
4.1 Investment opportunities and credit rationing: Theoretical framework 
Our empirical strategy builds upon the theoretical models of Stiglitz and Weiss (1981) and Bester 
(1985). Stiglitz and Weiss (1981) show that rationing may arise in competitive credit markets 
because information asymmetries can cause the supply curve for loans to bend backward. The reason 
for this result is that the lender’s expected return is not a monotonic increasing function of the 
interest rate r if the lender cannot discriminate between low risk (L) and high risk (H) projects 
(H>L). Thus a higher interest rate increases the revenues (if the bank gets repaid) on one side, but 
                                                 
14 As shown in Table 2, more than half of our final sample of SMEs declare no R&D expenditures and a “non-
rationed” status. 
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it also increases the proportion of applicants who are risky on the other side, thus the bank’s 
expected return starts to decrease when the second effect dominates the first one.  
This is the well known problem of adverse selection: the less risky firms drop out of the market as 
the interest rate rises. The main consequence is that, without any information on borrower’s quality, 
the bank maximizes its expected returns by setting the interest rate at the optimum level r*, 
obtained by “averaging” the unobserved parameter  from its distribution. The interest rate r* can 
be lower than the market clearing interest rate that would have been set in the absence of 
information asymmetries, thus generating equilibrium credit rationing. Bester (1985) extended the 
Stiglitz and Weiss (1981) model and emphasized the role of collateral (C) as an instrument that 
banks can use to discriminate between high-risk and low-risk projects by offering contracts with 
different combinations of collateral and interest rate. Different contracts can thus serve as a 
signalling mechanism because borrowers with a low probability of bankruptcy (i.e. borrowers with 
low-risk projects) are more inclined to accept an increase in collateral requirements in exchange for a 
reduction in the interest rate than borrowers with a high probability of failure (i.e. borrowers with 
high-risk projects). This leads to a separating equilibrium in which contracts with low r and high C 
are preferred and chosen by low-risk borrowers while contracts with high r and low C are instead 
preferred by high-risk borrowers. The possibility of credit rationing here arises when low-risk 
entrepreneurs are unable to raise a sufficient amount of collateral to distinguish themselves from 
high-risk ones. Indeed, low collateral availability might be a relevant cause of rationing for SMEs 
and, even more so, for small young firms. Hence we expect collateral (C) to be a relevant instrument 
in our setting. 
Using this framework, but simplifying matters, assume that the bank offers loan contracts with two 
different levels of collateral requirements (C’’>C’). A higher level of collateral allows the bank to 
offer the same amount of loan at a lower interest rate or to offer larger loans at a given interest rate: 
this is shown in Figure 1 as a right-ward shift of the backward-bending loan supply curve (S).  
The firm can choose to finance its desired level of investment by either internal resources or external 
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finance. The cost of the use of an additional unit of external finance is given by the interest rate r15, 
while the cost of using an additional unit of internal resources is given by the latent shadow cost , 
which is assumed to depend on both the amount of internal liquidity available to the firm and on the 
expected profitability of alternative investment opportunities. The optimal financing mix for the firm 
is obtained at the margin when r = . Thus demand for external finance D(r, ) will be decreasing 
with r (for a given ) and increasing with  (for a given r). The latter amounts to a right-ward shift 
in the demand curve, thus justifying the use of (a measure for)  as a relevant instrument. 
 
Figure 1 
The role of collateral (C) and of the opportunity cost of internal resources (λ)  
as “instruments” for detecting credit rationing 
 
Figure 1 illustrates the role of both collateral (C) and of the opportunity cost of internal resources (λ) 
as “instruments” for detecting credit rationing situations. Consider three different representative 
firms facing three different opportunity cost of internal resources (λ’’’>λ’’>λ’).  The firm facing λ’ can 
                                                 
15 We assume that the only available source of external finance is debt and that there is no pledging cost for 
collateral C. As we explained in Section 3, the assumption that debt financing is the only source of external 
finance for SMEs is consistent with our setting. 































choose (according to the riskiness of its investment projects and collateral availability) either a loan 
of amount L0 with interest rate r0 and collateral C’ or another one of amount L1 interest r1 and 
collateral C’’. In none of these cases this firm will be credit rationed (rationed = 0). Firm facing λ’’ 
will not be credit rationed if it can afford a collateral disposal of C’’, obtaining a loan amount of L3 
and paying an interest rate of r3, otherwise it will be able only to borrow L2 paying an interest of 
r*(C’). In the latter case the firm will be credit rationed (rationed = 1), with a desired extra amount of 
loan EDL’ at the given interest rate r*(C’). Finally, the firm facing λ’’’ can borrow a maximum 
amount of L4 by offering a collateral C’’ and paying an interest rate r*(C’’). This type of firm with 
high need for external funds will always be rationed (rationed = 1), with a desired amount of 
unfulfilled loan equal to EDL’’. 
 
4.2 Econometric model 
The model presented in the previous section drives our empirical strategy for estimating the 
marginal effect of being credit rationed on the decision to invest in R&D and on the amount of 
investment. In both cases the estimated model can be written as: 
 
·    
0
        (1) 
 
where , , y is either the binary variable representing the decision to invest in R&D or the 
actual amount of R&D investment. The function f(.) and the appropriate estimation method will be 
specified in section 5 according to the nature of y.  
As pointed out by Imbens and Angrist (1994) if the instruments affect the probability of being 
treated (i.e. being rationed) in the same way for all the units (i.e.  is constant across firms) then  can 
be interpreted as the average treatment effect (ATE). Otherwise, if  is individual-specific ( ) 
because of some forms of unobserved heterogeneity (Heckman et al. 2006) then the IV estimate of  
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can be interpreted (with the further assumption of “monotonicity”) as the local average treatment 
effect (LATE). The latter only identifies the average effect for the entities that are induced by a 
change in the instruments to change their rationed status (the “compliers”16).  
In our case the IV estimates of  can be interpreted as the average effect of being credit rationed on 
R&D investment for the sub-population of firms for which a change in the amount of collateral or in 
the latent opportunity cost λ is likely to affect the rationed status. In other words, both the “never 
takers” (i.e. the firms who are likely to report themselves as being not credit rationed - rationed = 0 - 
regardless of their amount of collateral or their λ) and the “always takers” (i.e. those firms who are 
likely to report themselves as being always credit rationed - rationed =1) are excluded from the IV 
estimate of .  
In our framework, where firms can self-select themselves as being credit rationed, we can have some 
forms of “spurious” positive correlation between y and rationed due to either the presence of low 
innovative-oriented firms who are likely to be always not rationed regardless of the values of Z 
(never takers) or by the presence of some forms of credit-addicted innovative firms who will always 
report themselves as being rationed regardless of Z (always takers). Thus the IV-LATE estimator 
may help in solving this puzzle by focusing on the population of compliers only.  
 
4.3 Instruments 
Using the theoretical model of credit rationing presented in section 4.1, we can assume that, 
conditional on the set of observable covariates (X), our instruments Z can predict the credit rationing 
status (rationed). We further assume that the instruments are independent of potential outcomes (y), 
by adopting, for each firm i, the one-year lagged values of the level of collateral (C) and of our 
measure of the latent opportunity cost of internal resources (λ).  
We therefore assume that: 
 
                                                 
16 The so-called population of “defiers” is excluded by the monotonicity assumption. 
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(i) The set of instruments Z is mean independent of the error term u conditional on X, i.e. 
| , 0, , . 
 
(ii) The probability of treatment choice is a non-trivial function of the instrument Z conditional 
on X, i.e.: 0. 
 
We cannot possibly obtain the pledged level of collateral, but we can calculate the available level of 
collateral from balance sheet data as the ratio between net tangible assets and total liabilities. 
However, available collateral should be a preferred exogenous instrument for credit rationing than 
pledged collateral, since the latter is more likely to be associated to the unobserved 
project/borrower’s risk (Steijvers and Voordeckers, 2009). 
We then need to find a measure for λ and we propose to use the Whited-Wu (2006) index of external 
financing constraints (WW) for this purpose. The WW index was first introduced by Whited and 
Wu (2006) as an alternative and improved index of financing constraints to the well-known Kaplan 
and Zingales (1997) index.17 It is obtained using structural investment model and estimated as: 
 
WW = -0.091*CF –0.062*DIVPOS +0.021*TLTD –0.044*LNTA +0.102*ISG –0.035SG.       (2) 
 
CF is the cash flow to total assets ratio, DIVPOS is a dummy equal to one when the firm pays cash 
dividends, TLTD is the long term debt to total assets ratio, LNTA is the natural log of total assets, 
ISG is the firm’s industry sales growth and SG is the firm sales growth, both calculated with respect 
to the previous year.  
As the components of WW clearly suggest, higher values of the index can be associated to higher 
need for external capital (Hennessy and Whited, 2007), i.e. a demand function shifted to the right 
                                                 
17 This has been recently confirmed by Hadlock and Pierce (2010), who find that the Kaplan and Zingales index 
is unlikely to be a useful measure of financial constraints, as the coefficients of most of its components flip sign 
across estimated models and in many cases turn out to be insignificant. 
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and a consequent higher likelihood of being subject to credit rationing.  
The difference in the means of the WW index18 between rationed and not rationed firms is 0.0108 
(statistically significant at the 5% level) for firms not performing R&D and is 0.0346 for firms with 
positive R&D (statistically significant at the 1% level). Thus a higher need of external financing and, 
hence, a higher likelihood of being credit rationed, as evidenced by the WW index, does translate in 
the firm’s own perception of being credit rationed, significantly more so for R&D performing firms. 
This suggests a positive relationship between our direct indicator of credit rationing and the WW 
index and thus increases our confidence in using the firm’s desire for additional finance to identify 
firms subject to credit rationing. While this reassures us about the relevance of the potential 
instrument, there might still be doubts about its actual exogeneity. Indeed, some of the components 
of the WW index could be correlated to the firm’s productivity (and, hence, R&D decision) even if we 
use predetermined values. We shall extensively deal with this issue in Section 5.3. 
Finally, we employ a further (and arguably more confidently exogenous) instrument that is not 
accounted for in our theoretical framework, but that is established in the literature (e.g. Herrera and 
Minetti, 2007): the number of bank branches per 1,000 inhabitants in the province of residence of the 
firm in 2001 (branches2001). This is a measure of the level of development of local credit markets 
(Benfratello et al., 2008) and is obtained from the Statistical Bulletin of the Bank of Italy and the 
2001 Census of the Italian National Statistics Office (ISTAT). We expect our branch density variable 
to be negatively related to the likelihood of credit rationing. 
We should now emphasise that there might be other potential instruments for the rationed variable. 
In particular, there exist an extensive literature discussing the role of relationship lending in 
mitigating the information asymmetry between borrower and lender (Petersen and Rajan, 1994; 
Boot, 2000; Berger and Udell, 2006). The proximity between borrower and lender allows the bank to 
better assess the quality of the firm and its investment projects, thus facilitating ex ante screening.  
                                                 
18 In calculating the WW index, we do not observe directly whether a generic firm i actually paid cash 
dividend in a given year t, but we retrieve this information by assuming that cash dividends are paid if the firm 
had positive net profits in year t and if the amount of net assets at the end of year t is less than the sum of net 
profits in year t plus the amount of net assets in year t-1. All other firm level right-hand side variables can be 
obtained from balance sheet data. Finally, ISG is calculated at the SIC three-digit level from AIDA. 
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In our survey data we have a widely used measure of the strength of the relationship between 
borrower and lender: the duration of the relationship with the main bank. An alternative measure of 
the closeness of the bank-firm relationship in our data is a dummy variable for the participation of a 
bank into the firm’s capital. None of these potential instruments is ever found relevant in our 
regressions. As a consequence, they will not be included in the specifications discussed in section 5.19 
 
5. Empirical analysis 
5.1 Covariates 
In our set of covariates X we include traditional determinants of R&D investment, starting with firm 
size, measured as the logarithm of the firm’s total number of employees (logEMP). As first suggested 
by Schumpeter (1942), firm size is likely to be a significant determinant of the decision to invest in 
R&D. One of the reasons is that R&D investment induces sunk costs. Large firms are therefore likely 
to be less reluctant to engage in R&D activities because they can spread such costs on more units of 
output (Cohen and Klepper, 1996). In addition, it may be easier for large firms to finance R&D 
investment as they are more likely to have internal financial resources and they may enjoy better and 
long established relations with external investors. Among others, Crépon et al. (1998) and also Bond 
et al. (2003) find a positive significant effect of firm size on the likelihood to undertake R&D. 
The impact of market structure and market shares on R&D investment and innovation has also been 
largely emphasized in the literature, starting, once again, with Schumpeter (1942), who argues that a 
firm has higher incentives to engage in R&D activities if it enjoys a monopoly position. On the 
contrary, Arrow (1962) shows that under perfect ex-post appropriation, profit margins are larger in 
an ex-ante competitive industry. Blundell et al. (1999) also find a positive relationship between firms’ 
ex ante market share and innovation. We therefore include in our specification the variable Mktshare, 
which is calculated as the firm’s share of the industry’s turnover in 2002. 
We also control for firm’s age (log(age)) as firms’ incentives to conduct R&D and its likelihood of 
                                                 
19 We also choose not to employ the set of instruments used by Herrera and Minetti (2007), which are found 
weak in our setting. See section 5.3 for further details. 
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incurring into credit rationing might differ with age. For example, successful R&D will be less 
valuable, ceteris paribus, for older firms with established products in the market and long-established 
relationship with banks might lower the cost of debt financing.  
We further introduce a dummy variable which is equal to one if the firm is the head of a group 
(grouphead). Groups include both national and international groups and might pursue different R&D 
strategies, affecting the distribution of their R&D effort within the group: e.g. parent companies 
might prefer to retain full control of R&D activities and then transfer technology directly to 
subsidiaries and foreign affiliates. For similar reasons, we include a dummy which takes the value of 
one if there is foreign participation into firm’s capital (foreign). Both the grouphead and foreign 
dummies might be expected to affect the likelihood of the firm facing credit rationing. Indeed, group 
membership accounts for the potentially relevant role of intra-group flows of resources for funding 
R&D projects and multinational corporations also create an internal capital market, which facilitates 
their subsidiaries’ access to external funds (Schiantarelli and Sembenelli, 2000). 
We also include a measure of the intensity of investment in physical assets to account for the 
potential trade-off or complementarity between R&D and physical investment (INV_EMP), and a 
measure of firm’s debt leverage equal to the ratio between firm’s long term debts and firm’s equity 
(DEBT_EQUITY). The latter is meant to account for the idea that a large debt burden can prevent a 
company from raising the funds to undertake new investment (Myers, 1977).  
Finally, we introduce a dummy variable to identify small firms according to the standard European 
definition (i.e. firms with less than 50 employees), a dummy equal to one if the firm is less than 10 
years of age, and their interaction. This set of dummies is meant to capture a potentially different 
propensity to do R&D by young and small companies. The same set of dummies will then be used to 
control for the additional difficulties that young and small companies are likely to face in obtaining 
sufficient bank financing to fund their R&D projects. Small companies are at a disadvantage because 
they cannot exploit scale economies and have fewer physical assets, and hence collateral, than more 
capital intensive firms. Young firms are similarly more likely to be financially constrained because 
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they will usually have low cumulated past profits to finance their R&D investment internally, they 
cannot benefit from long-term established relationships with local banks and typically have high 
default risk. Firms that are both young and small would face all the difficulties mentioned above. 
 
Table 3 – Variables definition and descriptive statistics (final sample of 2044 observations). 
Variable Description Mean St. dev. Min Max. 
dumRD =1 if invested in R&D in 2003;  0.343 0.475 0 1 
logRD log of firm’s R&D expenditures in 2003. 1.679 2.492 0 11.369 
rationed =1 if desired additional financing in 2003;  0.143 0.350 0 1 
logEMP Log. of firm’s total Employees in 2002  3.745 0.882 0 6.492 
INV_EMP Physical Investment /Total Employees in 2002 12.519 26.273 0 553.042 
Mktshare (Firm turnover/Sector turnover)*100 in 2002 0.021 0.041 0 0.901 
DEBT_EQUITY Long term debts /Firm’s equity  in 2002 1.282 8.671 -195.47 180.873 
North_East =1 if located in North-East Italy 0.322 0.467 0 1 
Centre =1 if located in Centre Italy 0.190 0.393 0 1 
South =1 if located in South Italy 0.148 0.356 0 1 
Log(age) =Log of firm’s age in years 3.179 0.594 1.099 4.644 
young =1 if the firm is less than 10 years of age 0.072 0.258 0 1 
small =1 if the firm has less than 50 employees 0.585 0.493 0 1 
grouphead =1 if is the leader of a group of firms 0.051 0.220 0 1 
foreign =1 if foreign participation in firm’s capital. 0.054 0.226 0 1 
WW Whited and Wu’s index calculated in 2002 -0.398 0.073 -0.675 -0.032 
Collateral Net Tangible Assets / Total liabilities  in 2002 0.643 0.388 0.013 7.445 
Branches 
Number of bank branches per 1,000 inhabitants 
by province in 2001 
0.592 0.143 0.218 1.010 
 
In all specifications we control for the likely effect of firm’s environment on its decision to undertake 
R&D investment through a complete set of industry dummies, which are primarily meant to capture 
the potentially relevant role of technological opportunities and appropriability conditions and the 
associated role of spillovers. We also include three geographical dummies, which identify firms 
located in the North-East (North_East), in the Centre (Centre) and in the South (South) of Italy, 
leaving regions located in the most industrialized North-West of Italy as the baseline. These 
dummies are thus particularly meant to account for the industrial divide in Italy between the 
industrialized northern regions vs. the less developed southern regions (which include some of the 
most disadvantaged regions in the EU).  
The list of variables employed in the analysis, their definition and descriptive statistics are reported 
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in Table 3. All continuous variables are predetermined and evaluated at 2002.  
 
5.2 Credit constraints and the R&D investment decision 
In estimating the model presented in section 4.2 when studying the R&D decision, we follow the 
Full Information Maximum Likelihood approach proposed by Gouriéroux et al. (1980) and Maddala 
(1983) by estimating a recursive bivariate probit model. This approach has been proposed to model 
the endogeneity problem when both the dependent variable and the endogenous covariate are binary. 
Equation (1) is here specified as: 
 
· 0
0                 
       (3) 
 
where  is equal to 1 if the firm undertakes R&D investment in 2003. The unobserved 






1          (4) 
 
,  measures the correlation between the unobservable terms and the variances of the 
error terms on the main diagonal are standardized to 1 for identification purposes (Maddala, 1983). If 
ρ = 0 then the likelihood of the bivariate probit model is simply equal to the sum of the likelihoods of 
the two univarate probit models.20  
Table 4, columns (2)-(4), report the estimated coefficients and marginal effects of the covariates 
included in equation (3) when considering the final sample of 2144 firms. In column (1) estimation 
results for the corresponding univariate probit model are reported for comparison.  
                                                 
20 Note also that the exclusion of dumRDi from the second equation in (3) implies that we meet coherency 
requirements and can estimate a partial-recursive bivariate probit model (see Gouriéroux et al., 1980; Lewbel, 
1997; Hajivassiliou and Savignac, 2011). 
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With reference to the preferred bivariate probit model, we find that the estimated coefficient 
associated with the rationed variable is negative and significant: taking into account its endogenous 
nature, the credit rationing indicator negatively affects the decision to engage in R&D activities, by 
reducing its likelihood by 22.4%.  
 
[Table 4 about here] 
 
Looking at the other regressors listed in columns (2) and (4) we notice that the likelihood of 
performing R&D increases with firm’s size and decreases when considering firms located in the 
south of Italy. This location effect reflects the well documented divide between the more advanced 
and industrialized northern regions in Italy vs. the less developed southern regions.  
Physical investment intensity is positively correlated with the probability of performing R&D, 
suggesting the existence of a potential complementarity relationship between intangible and tangible 
investment. Finally, the coefficient of the variable grouphead is positive and significant, suggesting a 
prevailing centralization strategy for R&D activities. 
With reference to the equation explaining the probability of being credit rationed, all instruments 
are highly significant. The WW index has the expected positive sign, while collateral negatively 
influences the probability of being credit rationed, thus confirming its role as a remedy for credit 
rationing. The excluded branch density variable shows, as expected, a negative and significant effect 
on the likelihood of credit rationing. Interestingly, while being young and small does not seem to 
affect the probability to conduct R&D directly, it significantly increases the chances to be credit 
rationed, and this is so after controlling for size, age, being young and being small. This implies that 
firms that are both young and small suffer an additional liability in finding sufficient resources to 
finance their R&D effort, which is therefore more likely to be discouraged. 
A formal test for the endogeneity of the variable rationed is the statistical significance of the 
estimated parameter ρ. We indeed estimate a positive and significant correlation between the 
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“unobservables” factors affecting both the probability of having positive R&D investment and the 
probability of being credit rationed. This can be interestingly related to the unexpected positive sign 
of the credit rationing indicator in the simple probit model, which is line with the results obtained in 
Savignac (2008) and Hajivassiliou and Savignac (2011) and might be the result of the positive 
correlation originated by the endogeneity bias associated with the credit rationing indicator. 
The apparent positive impact of financing constraints on the firms’ decision to invest in R&D when 
not controlling for endogeneity is likely to be generated by the important presence in the sample of 
firms not perceiving themselves as being subject to credit restrictions because they are not interested 
in innovation (either because of lack of entrepreneurial attitude or of promising technology and 
market opportunities) and hence do not wish to undertake R&D investment. The presence of these 
firms, representing a relatively large share of the sample, is a potential source of positive correlation 
between our credit rationing indicator and the R&D decision. This positive correlation may hide the 
negative impact of the first on the latter.  
A way to verify the relevance of this selection problem and to dig into the sources of endogeneity is 
to study the effect of credit rationing on the decision to undertake R&D investment by focusing on a 
sample of firms potentially willing to do R&D, so to eliminate the source of the confounding positive 
correlation (Savignac, 2008). We do that by excluding from our final sample 655 firms that do not 
undertake any R&D investment (R&D = 0), do not desire additional financing (rationed = 0) and have 
not completed any innovative project in the recent past.21 For this purpose, the survey includes a 
question asking whether in the previous three years the firm realized any (a) product innovation, (b) 
process innovation, (c) organizational or managerial innovation related to product or process 
innovations, (d) none of the above. Firms excluded from the sample have all selected the (d) option. 
We refer to the resulting reduced sample as including potentially “innovative firms”. 
Estimation results for the sub-sample of “potentially innovative” firms are reported in Table 4, 
columns (7)-(9). Interestingly, the coefficient of the credit rationing indicator is now negative and 
                                                 
21 Innovative activities are not necessarily associated with R&D investment in the survey, as they are treated in 
a different section. 
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statistically significant also in the simple probit regression (column (6)): potentially innovative firms 
facing credit rationing have a lower probability (of about -30%) to do R&D. The effects of the other 
variables are confirmed, with the exception of the physical investment intensity, which is no longer 
found significant. Indeed, the distribution of investment intensity of potentially innovative firms is 
slightly shifted to the right with respect to the whole sample, but it is fairly similar between the two 
groups of firms with and without R&D effort.  
The parameter ρ, although still positive, is, as should be expected, smaller than previously estimated 
and, furthermore, it’s no longer significant. By controlling for sample selection we therefore take 
care of most of the endogeneity bias, although the larger marginal effect of the “rationed” indicator in 
the bivariate probit regression (column (9)) compared to the simple probit regression (column (6)) 
suggests that other sources of endogeneity might be at work. 
Columns (5) and (10) in Table 4 report the instrumental variable (IV) estimates of equation (3) 
obtained from the limited information maximum likelihood (LIML) procedure.22 Results are robust 
with respect to the bivariate probit model and the larger coefficient and standard error of the rationed 
indicator in the IV approach with respect to the bivariate probit model estimates can be explained 
with the LATE interpretation of the IV coefficients (Imbens and Angrist, 1994) vs. the ATE 
interpretation of the bivariate probit marginal effects (Chiburis et al., 2010). 
The Sargan test, reported in the last row of columns (5) and (10), does not reject the null hypothesis 
of overidentifying restrictions, supporting the validity of our set of instruments. However Small 
(2007) discusses several cases in which the Sargan test has very low power versus many alternatives. 
Thus we now perform a sensitivity analysis in order to corroborate our results. 
 
5.3 Robustness and sensitivity analysis. 
In this section we perform some robustness checks and a (semi-bayesian) sensitivity analysis in order 
to assess the validity of our set of instruments. 
                                                 
22 Very similar results are obtained with a a two stage least squares (2SLS) procedure, which is therefore not 
reported. 
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We first focus on the evaluation of two omitted factors that contribute to the determination of the 
WW index and can be potentially missing as control variables in both the equations of model (3): 
these are  firm’s productivity and firm’s availability of internal financial resources. We then re-
estimate model (2) using two additional control variables: the log of the ratio of net sales per 
employee in 2002  as a proxy for firm’s productivity and the ratio of available internal cash flow over 
equity in 2002. Estimation results are not reported as they display no significant changes with 
respect the previous model specification.23 In particular the coefficient associated with the variable 
rationed keeps the same sign and a very similar magnitude with respect to the former specification. 
We next test the sensitivity of the effect of rationed on dumRD by relaxing the exclusion restriction 
concerning each of the instrumental variables involved in the estimation of model (2), using the 
methodology proposed by Conley et al. (2012). We thus deal with our earlier concern on the 
potential endogeneity of our set of instruments and, in particular, of the WW index. 
We adopt the so-called “Local-to-Zero” approximation and use as reference model the IV-2SLS 
specification estimated in Table 5, column (1). This approach treats  as being local-to-zero in the 
following linear equation system: 
 
        (5) 
 
which is obtained by linearizing model (3) and by setting , 
,  (i.e. by defining the original dependent, treatment and 
instrumental variables as residuals from the projection upon the space defined by the set of 
exogenous regressors X.) 
The local-to-zero estimation approach involves the following approximation (see Conley et al., 2012): 
 
                                                 
23 They are however available from the authors upon request. 
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~ ,           (6) 
where 
̃ ̃ ̃   and         (7) 
 
 is the standard variance-covariance matrix of the 2SLS estimator. The bias term  is called 
“exogeneity error” and depends on the sample moments in matrix A and on the prior distribution F 
for , which reflects the deviations of  from the asymptotic standard  distribution of 2SLS 
estimators caused by violations of the “exclusion restriction” assumption.  
 
Figure 2 
95% interval estimates for the effect of rationed on dumRD across various prior settings. 
 
 
As stressed by Conley et al. (2012), one of the advantages of this approach is that the relationship 



















































size of A (which is inversely related to the strength of the instruments) determines how strongly 
exogeneity errors affect inference on . 
We apply the simplest implementation of the Local-to-Zero approach by specifying a multivariate 
normal prior for , 0, , and computing the 95% confidence intervals for  corresponding 
to different values of , after having standardized all variables in the instrument matrix Z. The 4 
panels of Figure 2 show the computed 95% confidence intervals for  with respect to different prior 
settings. In the first panel we set 1,0,0 , i.e. we allow only the standard deviation of 
WW to vary and set to zero the variance of the parameters associated with the remaining 
instruments collateral and branches. In the second panel we set 0,1,0 , i.e. we allow only 
the standard deviation of collateral to vary, while in the third one we set 0,0,1 , i.e. we 
allow only the standard deviation of branches to vary. Finally, in the last panel we set 
1,1,1 , thus allowing the standard deviation of all instruments to vary. 
In order to evaluate whether the plotted intervals are informative or not we need a set of benchmark 
values for the “plausible” effect of the excluded instruments. We obtain them by estimating the effect 
of the excluded instruments on dumRS using a 2SLS approach: Table 5 replicates the sequence of the 
quadrants  of Figure 3 by including in the main R&D equation one of the instruments at a time 
(columns 2-4) and the whole set of instruments (column 5).  
 
[Table 5 about here] 
 
Before commenting the results we have to clarify that, since the 2SLS estimates of column 5 would 
be unfeasible without an “extra” set of instrumental variable, we used as additional set of instruments 
the ones adopted by Herrera and Minetti (2007). These instrumental variables are proxies for the 
structure of local baking market in Italy in 1936.24 Their exclusion restriction can be plausibly 
justified in term of theoretical considerations but they have the disadvantage of being only weakly 
                                                 
24 See Herrera and Minetti (2007) for a more detailed description of the instrumental variables. 
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correlated with our treatment variable. Because of the potential dangers of using weak instruments 
(Bound et al. 1995) we restrict their use to this section only. The 2SLS regressions in Table 6 show 
that the estimated magnitude of the effects of the excluded instruments on the dependent variable are 
very small (and not significant): the 95% confidence interval for the effect of WW (which seems to be 
the less “plausible” exogenous instruments) is (-0.061, 0.01) according to the 2SLS estimates of 
column 2 and (-0.079, 0.029) according to the 2SLS estimates of column 5. By assuming a normal 
prior distribution with zero mean and standard deviation 0.03 we are considering a confidence 
interval for  approximately equal to (-0.06, +0.06), which contains most of the range of the 
previously estimated effect. The plot of the local-to-zero estimator reported in the first quadrant of 
the Figure 3 shows that our treatment variable is still statistically significant (and negative) even 
when considering this level of uncertainty on the plausibility of the exclusion restriction of WW. 
 
5.4 Credit rationing and the size of R&D investment 
We now turn to the analysis of the effect of credit rationing on the size of R&D investment. We 
employ an instrumental variable Tobit25 (IV-Tobit) model, to account for the endogeneity of our 




        (8) 
 
where  is the logarithm of the latent level of firm’s R&D investment in 2003, which is left-
censored at zero:  
 
·       0
0                                                                         0
    (9) 
                                                 
25 The distribution of the logarithm of R&D expenditures (over positive values) for the entire sample: the 
distribution is bell shaped and sufficiently close to Normal (Skewness/Kurtosis Normality test: 2.69; P>chi2(2): 
0.260), thus justifying the use of the Tobit model. 
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The endogeneity of rationed is treated both via the two-step Newey procedure, by inserting the fitted 
values of vi into the first equation, and via full ML techniques, by specifying a full variance-
covariance matrix of the error terms (ui, vi): 
 
, Σ          (10) 
 
The procedure applies to any kind of endogenous variables, including binary variables. 
Table 6 reports the IV-Tobit estimation output for the final sample, using both the two-step (column 
(2)) and ML (columns (3) to (6)) procedures. Column (1) shows the output for the standard Tobit 
regression, which is reported for comparison, and confirms that ignoring endogeneity and sample 
selection induces a bias in the effect of credit rationing, which is found positive, although, differently 
from the probit setting, it is not significant in the final sample. Once again, controlling for 
endogeneity, the effect of credit rationing on the level of R&D is found significant and has the 
expected sign. Our results also confirm the complementarity between tangible and intangible 
investment and the positive effect of firm size and of the firm being the head of a group.  
The probability of being credit rationed is again positively related to the WW index and negatively 
to the size of collateral and to branch density. The additional liability of being both young and small 
is again confirmed. The Wald test of exogeneity strongly rejects the null hypothesis of independence 
between the error terms of the two equations. Indeed we find a positive and strongly significant 
correlation between the errors (σuv=9.08). 
 
[Table 6 about here] 
 
Columns (7)-(12) in Table 7 report similar estimation results for the subsample of potentially 
innovative firms. Analogously to estimation results on the R&D decision for the same sample, credit 
rationing negatively and significantly affects the size of R&D investment also in the simple Tobit 
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regression. The effects of the other variables are confirmed. Similarly to the bivariate probit model, 
we find a weaker correlation between the error terms in the two equations when considering the 
subsample of potentially innovative firms (σuv=4.26). Differently from the bivariate probit model, 
however, the correlation here is still positive and significant, confirming our initial intuition that not 
all of the endogeneity bias can be accounted for by excluding firms uninterested in innovation. 
Columns (5) and (11) in Table 6 report marginal effects for all explanatory variables on the 
probability of doing R&D, while columns (6) and (12) report marginal effects on the expected value 
of logRD conditional on positive values. However, we’re mostly interested in disentangling the 
negative effect of credit rationing on R&D into the reduction due to firms deciding not to pursue 
R&D and the reduction in R&D investment due to firms reducing their (positive) R&D effort. For 
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The first component is the percentage reduction in R&D due to the reduced probability of pursuing 
R&D investment, while the second component is the percentage reduction in R&D due to the 
reduced amount of R&D investment, conditional on there being R&D investment in the first place. 
The two components are respectively -2.17 and -1.04 for the full sample and -1.81 and -1.04 for the 
sample of potentially innovative firms. This result confirms that, in relative terms, most of the 
negative effect of credit rationing on the observed level of R&D investment is due to firms deciding 
not to pursue R&D activities.  
 
6. Conclusions 
This paper aims at assessing the effect of credit rationing on R&D investment for SMEs. Our 
contribution to the existing literature is twofold. First, we show that the effect of credit rationing on 
the decision to invest in R&D and its effect on the size of the R&D investment (conditional on the 
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investment decision) are different and, as a consequence, should be separately evaluated. Second, we 
innovatively use the WW index as one of the instruments for our direct indicator of rationing and 
provide a theory-based identification strategy. A sensitivity analysis based on the recent contribution 
by Conley et al. (2012) is then used to deal with potential concerns on instruments’ exogeneity. 
Our empirical findings support the assumption that credit rationing significantly reduces both the 
probability of doing R&D and the level of R&D investment. We further measure the percentage 
reduction in R&D investment as a consequence of the firm facing credit rationing and split it into its 
two components: the first is due to the reduction in the likelihood to do R&D (the R&D participation 
decision), and the second is due to a reduced level of investment, conditioned on the R&D decision. 
Our results show that most of the reduction is to be attributed to the first effect: credit rationing 
primarily affects the proportion of firms doing R&D (the extensive margin), rather than the expected 
level of R&D investment for firms already doing R&D (the intensive margin). This result implicitly 
suggests that credit rationing is more likely to discourage new R&D investment than to reduce 
investment expenses in ongoing R&D projects.  
A further contribution of our work relates to the liability suffered by young and small firms in 
obtaining external financing. Their R&D effort is, ceteris paribus, more likely to be discouraged 
because it will be more difficult for them to obtain sufficient funds from external sources to finance it. 
As a consequence, credit rationing seriously hinders the post-entry growth of small young 
businesses, as discussed by Aghion et al (2007). Furthermore, given the pivotal role that young and 
small innovative companies have in bringing radically new innovations to market, credit rationing 
also represents a serious obstacle to the process of creative destruction and to the realization of the 
social benefits from breakthrough innovations that small and young firms might introduce. 
Significant policy efforts should therefore be devoted to improving financial markets in bank-based 
systems, which do not provide satisfactory financial support to R&D investment for SMEs. Both 
private credit and stock market capitalization are important for promoting R&D and innovation by 
SMEs and, consequently, their growth and their direct and indirect benefits to society.  
 31
Table 4 – Estimation output – R&D decision. 
 Final sample (observations: 2144) Innovative firms (observations: 1489) 
 Probit Bivariate Probit IV-LIML Probit Bivariate Probit IV-LIML 
 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) 
Dependent variable dumRD dumRD rationed dumRD dumRD dumRD rationed dumRD dumRD dumRD 
 Marg. Effects Coefficients Coefficients Marg. Effects Marg. Effects Coefficients Coefficients Marg. Effects Coefficients Coefficients 
rationed 0.0579* -0.718**  -0.224*** -0.702*** -0.124*** -0.792**  -0.299** -0.495** 
 (0.0318) (0.309)  (0.0801) (0.263) (0.0339) (0.354)  (0.120) (0.195) 
logEMP 0.0876*** 0.213*** 0.0457 0.0777*** 0.0656*** 0.0757** 0.165** -0.0156 0.0657** 0.0474* 
 (0.0260) (0.0651) (0.0774) (0.0236) (0.0251) (0.0307) (0.0762) (0.0858) (0.0304) (0.0287) 
INV_EMP 0.0008** 0.0021* 0.0005 0.0008* 0.000668 -0.0003 -0.001 -0.0017 -0.0004 -0.0005 
 (0.0004) (0.0012) (0.0013) (0.0004) (0.000430) (0.0004) (0.0013) (0.0015) (0.0005) (0.0005) 
DEBT_EQUITY 0.0005 0.0026 0.0056 0.0009 0.00134 0.0002 0.0011 0.0053 0.0005 0.0006 
 (0.0012) (0.0037) (0.0035) (0.0013) (0.00134) (0.0017) (0.004) (0.0037) (0.0016) (0.0015) 
mktshare 0.260 0.492 -0.0637 0.179 0.0977 0.297 0.607 -0.149 0.242 0.192 
 (0.318) (0.776) (0.899) (0.282) (0.324) (0.374) (0.861) (0.954) (0.343) (0.328) 
North_east -0.0270 -0.0540 0.222** -0.0196 -0.0133 -0.0188 -0.0301 0.272** -0.0120 -0.0037 
 (0.0260) (0.0717) (0.0954) (0.0258) (0.0285) (0.0340) (0.0855) (0.106) (0.0341) (0.0323) 
Centre -0.0413 -0.0767 0.175* -0.0276 -0.0115 -0.0575 -0.120 0.165 -0.0477 -0.0328 
 (0.0299) (0.0872) (0.104) (0.0310) (0.0346) (0.0395) (0.103) (0.116) (0.0407) (0.0388) 
South -0.123*** -0.235** 0.236 -0.0820** -0.0335 -0.153*** -0.300** 0.266 -0.118** -0.0759 
 (0.0322) (0.115) (0.151) (0.0380) (0.0475) (0.0455) (0.137) (0.170) (0.0527) (0.0537) 
Log(age) 0.0017 0.0112 0.0585 0.004 0.00748 0.0068 0.0255 0.0883 0.0102 0.0140 
 (0.0233) (0.0634) (0.0764) (0.0231) (0.0247) (0.0300) (0.0759) (0.0856) (0.0303) (0.0284) 
young -0.0472 -0.151 -0.315 -0.0533 -0.0771 -0.0355 0.0248 -0.179 0.0099 0.0110 
 (0.0418) (0.189) (0.258) (0.0646) (0.0775) (0.0508) (0.236) (0.286) (0.094) (0.0885) 
small -0.0449 -0.141 -0.0748 -0.0515 -0.0663 -0.143 -0.0937 -0.0378 -0.0374 -0.0427 
 (0.0806) (0.106) (0.128) (0.0389) (0.0422) (0.106) (0.124) (0.142) (0.0494) (0.0468) 
young*small -0.0359 -0.0056 0.601** -0.002 0.0556 0.0189 -0.292 0.520* -0.115 -0.0830 
 (0.0681) (0.233) (0.282) (0.0847) (0.0934) (0.0965) (0.284) (0.316) (0.108) (0.106) 
grouphead 0.155*** 0.350*** -0.238 0.134** 0.109** 0.163*** 0.377** -0.316 0.148** 0.107* 
 (0.0526) (0.132) (0.179) (0.0522) (0.0525) (0.0581) (0.158) (0.195) (0.0598) (0.0562) 
foreign 0.0220 0.0823 0.132 0.0304 0.0442 0.0551 0.156 0.175 0.0619 0.0682 
 (0.0495) (0.124) (0.152) (0.0463) (0.0509) (0.0636) (0.150) (0.167) (0.0593) (0.0564) 
WW   2.668***     3.248***   
   (0.577)     (0.669)   
collateral   -0.226**     -0.283**   
   (0.108)     (0.129)   
branches   -1.190***     -1.445***   
   (0.386)     (0.441)   
Rho  0.539**    0.295   
Shea Partial R-sq    0.015*** [0.00]     0.026***[0.00] 
Under-identific. LM 
test 
   32.59*** [0.00]     40.09*** [0.00] 
Sargan stat    4.931[0.177]     3.997 [0.262] 
Log Lik -1233.9525 -2073.1291   -918.00975 -1619.5739   
Robust standard errors in parentheses (Observed Information Matrix method). P-values in square brackets. Constant and industry dummies included in all regressions. 
* significant at 10%; ** significant at 5%; *** significant at 1%. 
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Table 5 – Sensitivity analysis – 2SLS-IV benchmark estimates - Final sample (observations: 2144). 
 (1) (2) (3) (4) (5) 
Dependent variable dumRD dumRD dumRD dumRD dumRD 
rationed -0.678*** -0.374 -0.754*** -0.796*** -0.342 
 (0.242) (0.322) (0.273) (0.302) (0.587) 
WW 
 (standardized)  -0.025   -0.0267 
  (0.019)   (0.0264) 
collateral 
 (standardized) 
  -0.007  -0.0011 
   (0.013)  (0.0138) 
branches 
 (standardized)    -0.015 0.0017 
    (0.022) (0.0270) 
      
Instruments:      
      
WW 
(standardized) 
Yes  Yes Yes  
      
collateral 
 (standardized) Yes Yes  Yes  
      
branches 
 (standardized) Yes Yes Yes   
      
Shea Partial R-sq 0.0173** [0.00] 0.008** [0.021] 0.015*** [0.00] 0.012*** [0.00] 0.002 
 [0.584] 
Under-identific. LR test 37.43** [0.00] 18.27** [0.019] 31.83*** [0.00] 
26.55*** 
[0.00] 
4.76   
 [0.575] 














 [0.813]   
0.086  
[0.769] 











      
Robust standard errors in parentheses. P-values in squared brackets. All models include the full set of control variables as well as Herrera and Minetti (2007) instruments. 
* significant at 10%; ** significant at 5%; *** significant at 1% 
(1) These include: logEMP, INV_EMP, DEBT_EQUITY, mktshare, North_east, Centre, South, Log(age), young, small, young*small, grouphead, foreign. 
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Table 6 – Tobit Estimation output – size of R&D investment. 
Dependent 
variable 




ML IV – Tobit Tobit ML 
Two-Step 
IV-Tobit 
ML IV – Tobit 
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) 
logRD logRD logRD rationed dumRD 
E(logRD| 
logRD>0) 














rationed 0.605 -10.98*** -11.91***  -0.4538*** -2.6436*** -1.277*** -5.391*** -5.842***  -0.4652*** -1.8806*** 
 (0.388) (3.827) (4.207)  (0.0784) (0.6742) (0.338) (1.980) (2.247)  (0.1429) (0.5923) 
logEMP 1.479*** 1.240*** 1.225*** 0.002 0.0695*** 0.3775*** 1.070*** 0.877*** 0.858*** -0.0091 0.0741*** 0.3382*** 
 (0.350) (0.365) (0.403) (0.0178) (0.0228) (0.1242) (0.293) (0.291) (0.317) (0.0235) (0.0274) (0.1249) 
INV_EMP 0.0138*** 0.0136** 0.0136** 0.0001 0.0007** 0.0042** 0.0017 -0.000706 -0.001 -0.0003 -0.0001 -0.0004 
 (0.0047) (0.0062) (0.00548) (0.0003) (0.0003) (0.0017) (0.0052) (0.00485) (0.0058) (0.0003) (0.0005) (0.0023) 
DEBT_EQUITY 0.0034 0.0203 0.0217 0.0014 0.0012 0.0067 -0.0014 0.00544 0.0062 0.0015 0.0005 0.0024 
 (0.0163) (0.0217) (0.0273) (0.0015) (0.0015) (0.0085) (0.0172) (0.0167) (0.0215) (0.0019) (0.0019) (0.0085) 
mktshare 3.710 1.376 1.190 -0.0393 0.0675 .03667 2.925 1.931 1.828 -0.0416 0.1579 0.7205 
 (3.944) (4.489) (3.945) (0.335) (0.2238) (1.2161) (3.316) (3.275) (2.690) (0.386) (0.2325) (1.06) 
North_east -0.412 -0.186 -0.169 0.0406** -0.0096 -0.052 -0.244 -0.111 -0.0968 0.0627** -0.0084 -0.0381 
 (0.333) (0.408) (0.407) (0.0197) (0.0230) (0.1247) (0.293) (0.323) (0.320) (0.0274) (0.0277) (0.1257) 
Centre -0.494 -0.0904 -0.0587 0.0379* -0.0033 -0.0181 -0.454 -0.275 -0.256 0.0448 -0.0222 -0.0999 
 (0.407) (0.503) (0.510) (0.0216) (0.0289) (0.1567) (0.364) (0.393) (0.402) (0.0292) (0.0348) (0.1551) 
South -1.91*** -0.590 -0.488 0.0703** -0.0275 -0.1481 -1.658*** -0.964* -0.893 0.0957** -0.0776 -0.3377 
 (0.509) (0.710) (0.757) (0.0341) (0.0421) (0.2263) (0.462) (0.560) (0.610) (0.0487) (0.0531) (0.2213) 
Log(age) 0.001 0.0872 0.0943 0.0098 0.0053 0.0291 0.0480 0.125 0.134 0.0211 0.0116 0.0527 
 (0.300) (0.360) (0.368) (0.0168) (0.0209) (0.1135) (0.266) (0.288) (0.290) (0.0231) (0.025) (0.1142) 
young -0.658 -0.976 -1.030 -0.0627 -0.0572 -0.3052 -0.410 0.187 0.168 -0.0458 0.0145 0.0669 
 (0.548) (1.088) (1.065) (0.0440) (0.0576) (0.3034) (0.468) (0.863) (0.832) (0.0653) (0.0715) (0.3341) 
small -0.811 -0.909 -0.929 -0.0279 -0.0528 -0.2885 -1.570 -0.472 -0.480 -0.0202 -0.0415 -0.1899 
 (1.149) (0.608) (0.646) (0.0278) (0.0368) (0.2022) (1.021) (0.472) (0.492) (0.0368) (0.0424) (0.1951) 
young*small -0.299 0.618 0.729 0.128** 0.0418 0.2316 0.367 -0.972 -0.911 0.146* -0.0792 -0.3401 
 (0.914) (1.376) (1.376) (0.0577) (0.0798) (0.4503) (0.796) (1.088) (1.083) (0.0831) (0.0943) (0.3828) 
grouphead 1.886*** 1.408* 1.373** -0.0345 0.0794** 0.4474* 1.499*** 1.230** 1.203** -0.0532 0.1014** 0.5081** 
 (0.545) (0.719) (0.677) (0.0284) (0.0397) (0.2332) (0.459) (0.546) (0.503) (0.0337) (0.041) (0.2269) 
foreign 0.469 0.802 0.829 0.0262 0.0476 0.2642 0.691 0.861 0.881 0.0411 0.0749 0.3655 
 (0.599) (0.704) (0.757) (0.0349) (0.044) (0.2495) (0.519) (0.548) (0.564) (0.0461) (0.0469) (0.2459) 
WW    0.608***      0.910***   
    (0.121)      (0.171)   
collateral    -0.0285*      -0.0572*   
    (0.0153)      (0.0295)   
branches    -0.212**      -0.341***   
    (0.0829)      (0.127)   
Log Lik -2971.2525  -3716.3634    -2606.6562  -3312.8941    
Wald test (σ uv=0)  13.35 *** 9.08 ***     5.08 ** 4.26 **    
Robust standard errors in parentheses. Constant and industry dummies included in all regressions. 
  * significant at 10%; ** significant at 5%; *** significant at 1% 
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